Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleArticle

α5 Subunit Alters Desensitization, Pharmacology, Ca++ Permeability and Ca++ Modulation of Human Neuronal α3 Nicotinic Receptors

Volodymyr Gerzanich, Fan Wang, Alexander Kuryatov and Jon Lindstrom
Journal of Pharmacology and Experimental Therapeutics July 1998, 286 (1) 311-320;
Volodymyr Gerzanich
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fan Wang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alexander Kuryatov
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jon Lindstrom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Functional effects of human α5 nicotinic ACh receptor (AChR) subunits coassembled with α3 and β2 or with α3 and β4 subunits, were investigated in Xenopus oocytes. The presence of α5 subunits altered some properties of both α3 AChRs and differentially altered other properties of α3β2 AChRs vs. α3β4 AChRs. α5 subunits increased desensitization and Ca++permeability of all α3 AChRs. The Ca++ permeabilities of both α3β2α5 and α3β4α5 AChRs were comparable to that of α7 AChRs. As we have shown previously, α5 subunits increased the ACh sensitivity of α3β2 AChRs 50-fold but had little effect on α3β4 AChRs. α5 caused only subtle changes in the activation potencies of α3 AChRs for nicotine, cytisine and 1,1-dimethyl-4-plenylpiperazinium (DMPP). However, α5 increased the efficacies of nicotine and DMPP on α3β2 AChRs but decreased them on α3β4 AChRs. Immunoisolation of cloned human AChRs expressed in oocytes showed that α5 efficiently coassembled with α3 plus β2 and/or β4 subunits. As expected, human AChRs immunoisolated from SH-SY5Y neuroblastoma cells showed that AChRs containing α3 and probably α5 subunits were present, but α4 AChRs were not. In brain, by contrast, α4β2 AChRs were shown to predominate over α3 AChRs. Some of the brain α4β2 AChRs were found to contain α5 subunits.

Footnotes

  • Send reprint requests to: Dr. Jon Lindstrom, 217 Stemmler Hall, 36th and Hamilton Walk, Philadelphia, PA 19104-6074.

  • ↵1 Research in the laboratory of J.L. is supported by grants from the NIH (NS11323), the Smokeless Tobacco Research Council, Inc., The Council for Tobacco Research–USA, Inc., and the Muscular Dystrophy Association.

  • Abbreviations:
    AChR
    acetylcholine receptor
    mAb
    monoclonal antibody
    DMPP
    1,1-dimethyl-4-phenylpiperazinium
    • Received November 6, 1997.
    • Accepted March 2, 1998.
  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text

JPET articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 286, Issue 1
1 Jul 1998
  • Table of Contents
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
α5 Subunit Alters Desensitization, Pharmacology, Ca++ Permeability and Ca++ Modulation of Human Neuronal α3 Nicotinic Receptors
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

α5 Subunit Alters Desensitization, Pharmacology, Ca++ Permeability and Ca++ Modulation of Human Neuronal α3 Nicotinic Receptors

Volodymyr Gerzanich, Fan Wang, Alexander Kuryatov and Jon Lindstrom
Journal of Pharmacology and Experimental Therapeutics July 1, 1998, 286 (1) 311-320;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

α5 Subunit Alters Desensitization, Pharmacology, Ca++ Permeability and Ca++ Modulation of Human Neuronal α3 Nicotinic Receptors

Volodymyr Gerzanich, Fan Wang, Alexander Kuryatov and Jon Lindstrom
Journal of Pharmacology and Experimental Therapeutics July 1, 1998, 286 (1) 311-320;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • CRV431 Decreases Liver Fibrosis and Tumor Development
  • Streptococcus pneumoniae Pneumonia in Mice: Optimal Amoxicillin Dosing Predicted from a Pharmacokinetic-Pharmacodynamic Model
  • Tissue Selectivity of Antidiabetic Agent Nateglinide: Study on Cardiovascular and β-Cell KATP Channels
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics